Rothschild Capital Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Rothschild Capital Partners's LLY Position: Q2 2026 in Review
Rothschild Capital Partners increased its Eli Lilly (LLY) stake by 23% in Q2 2026, buying an estimated $197K and bringing the position to 1,030 shares worth $1.24M. The position accounts for 0.26% of the portfolio, ranked #39.
Rothschild Capital Partners first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.63M in Q4 2025. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Rothschild Capital Partners held 1,030 shares of Eli Lilly worth $1.24M as of Q2 2026.
- Rothschild Capital Partners bought 193 Eli Lilly shares in Q2 2026, an estimated $197K.
- Eli Lilly made up 0.26% of Rothschild Capital Partners's portfolio in Q2 2026, its #39 holding.
- Rothschild Capital Partners first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
- Rothschild Capital Partners's Eli Lilly position peaked at $1.63M in Q4 2025.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Rothschild Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.